US 10407466
Methods of selecting compstatin mimetics
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10407466 (Methods of selecting compstatin mimetics) held by Apellis Pharmaceuticals, Inc. expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apellis Pharmaceuticals, Inc.
- Grant date
- Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K31/00, A61K31/7105